INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.63
0.00%
(0.00) 1D
$1.61
arrow_downward
-1.39% (-0.023)todayPre-market
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Mkt. cap
305.31M
Avg. vol.
19.92M
Volume
222.22K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Mkt. cap
305.31M
Avg. vol.
19.92M
Volume
222.22K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
46 minutes ago
Inovio submits European approval application for RRP treatment
Yahoo Finance
·
11 hours ago
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
The Business Journals
·
1 day ago
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com